Liz Cornish is the senior digital marketing & brand manager for BA Sciences outlines key steps facility teams can take to investigate, remediate, and prevent pharmaceutical contamination.
David Staunton, industry transformation leader at Cognizant Life Science Manufacturing shares how life sciences companies are under immense pressure to deliver new treatments to a global population faster.
Neil Smith, CPG president, Schneider Electric comments on the importance of the upcoming UK Point of Care manufacturing legislation that came into force today (23rd July 2025).
Professor Philipp Koellinger, co-founder and CEO of open science startup DeSci Labs, argues that peer review needs urgent reform and that AI can help pharma live up to its ideals.
New environmental regulations and increasing consumer demand for corporate sustainability drive European pharmaceutical companies to commit to green chemistry processes. Ellie Gabel, associate editor for Revolutionized discusses.
The UK government has announced a new Life Sciences Sector Plan aimed at strengthening the economy and modernising the NHS, marking a significant step in its wider Industrial Strategy.
For too long, regulatory teams have become bogged down by protracted reviews of the regulatory implications. Generative AI (GenAI) promises to change all that, say independent consultant Preeya Beczek and Agnes Cwienczek of ArisGlobal.
PSI CRO explores solid site relationships and how they are the backbone of successful clinical trials. Without happy, supported sites, enrolment simply cannot happen predictably or within budgetary constraints.
PSI, a global Contract Research Organisation, explains why selecting a global safety database is one of the most critical decisions in managing clinical trial data.
Mark Fish, VP and GM of Digital Lab Solutions discusses the importance of making automation more accessible for labs across industries with the next generation of innovation.
Ellen Varelas, founder & CEO of LectureLinx, a global provider of innovative compliance technology and services solutions for the bio-pharmaceutical industry discusses the importance of compliance in the pharma industry.
